UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 283

Sortiert nach

Pegfilgrastim prophylaxis is associated with a lower risk of hospitalization of cancer patients than filgrastim prophylaxis: a retrospective United States claims analysis of granulocyte colony-stimulating factors (G-CSF)

BMC cancer, 2013-01, Vol.13 (1), p.11-11, Article 11

2013

Link zum Volltext

Verfügbarkeit prüfen

Patterns of biologic agent utilization among patients with rheumatoid arthritis: a retrospective cohort study

BMC musculoskeletal disorders, 2011-09, Vol.12 (1), p.204-204, Article 204

2011

Link zum Volltext

Verfügbarkeit prüfen

Opioid Prescribing for Opioid-Naive Patients in Emergency Departments and Other Settings: Characteristics of Prescriptions and Association With Long-Term Use

Annals of emergency medicine, 2018-03, Vol.71 (3), p.326-336.e19

2018

Link zum Volltext

Verfügbarkeit prüfen

Severe Hypoglycemia Attributable to Intensive Glucose-Lowering Therapy Among US Adults With Diabetes: Population-Based Modeling Study, 2011-2014

Mayo Clinic proceedings, 2019-09, Vol.94 (9), p.1731-1742

2019

Link zum Volltext

Verfügbarkeit prüfen

Trends in opioid use in commercially insured and Medicare Advantage populations in 2007-16: retrospective cohort study

BMJ (Online), 2018-08, Vol.362, p.k2833

2018

Link zum Volltext

Verfügbarkeit prüfen

Health Care Costs and Resource Utilization, Including Patient Burden, Associated With Novel‐Agent‐Based Treatment Versus Other Therapies for Multiple Myeloma: Findings Using Real‐World Claims Data

The oncologist (Dayton, Ohio), 2013-01, Vol.18 (1), p.37-45

2013

Link zum Volltext

Verfügbarkeit prüfen

Methods and Study Design for Cancer Health Economics Research: Summary of Discussions From a Breakout Session

Journal of the National Cancer Institute. Monographs, 2022-07, Vol.2022 (59), p.95-101

2022

Link zum Volltext

Verfügbarkeit prüfen

Maternal comorbidity and adverse perinatal outcomes in survivors of adolescent and young adult cancer: A cohort study

BJOG : an international journal of obstetrics and gynaecology, 2023-06, Vol.130 (7), p.779-789

2023

Link zum Volltext

Verfügbarkeit prüfen

Idiopathic pulmonary fibrosis in the United States: time to diagnosis and treatment

BMC pulmonary medicine, 2023-08, Vol.23 (1), p.281-10, Article 281

2023

Link zum Volltext

Verfügbarkeit prüfen

Long-term antimüllerian hormone patterns differ by cancer treatment exposures in young breast cancer survivors

Fertility and sterility, 2022-05, Vol.117 (5), p.1047-1056

2022

Link zum Volltext

Verfügbarkeit prüfen

Real-world Analysis of Tyrosine Kinase Inhibitor Treatment Patterns Among Patients With Chronic Myeloid Leukemia in the United States

Clinical therapeutics, 2015, Vol.37 (1), p.124-133

2015

Link zum Volltext

Verfügbarkeit prüfen

Sexually Transmitted Infection Testing and Prevalence Before and After Preexposure Prophylaxis Initiation Among Men Aged ≥18 Years in US Private Settings

Sexually transmitted diseases, 2021-07, Vol.48 (7), p.515-520

2021

Link zum Volltext

Verfügbarkeit prüfen

Percutaneous Left Atrial Appendage Occlusion in Comparison to Non-Vitamin K Antagonist Oral Anticoagulant Among Patients With Atrial Fibrillation

Journal of the American Heart Association, 2022-10, Vol.11 (19), p.e027001

2022

Link zum Volltext

Verfügbarkeit prüfen

Association of Generic Imatinib Availability and Pricing With Trends in Tyrosine Kinase Inhibitor Use in Patients With Chronic Myelogenous Leukemia

JAMA oncology, 2020-12, Vol.6 (12), p.1969

2020

Link zum Volltext

Verfügbarkeit prüfen

A Population-based Study of Immunotherapy-related Toxicities in Lung Cancer

Clinical lung cancer, 2020-09, Vol.21 (5), p.421-427.e2

2020

Link zum Volltext

Verfügbarkeit prüfen

An Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients With Advanced Non-Small-Cell Lung Cancer

JCO clinical cancer informatics, 2019-07, Vol.3, p.1

2019

Link zum Volltext

Verfügbarkeit prüfen

Estimating recommended gonorrhea and chlamydia treatment rate using linked medical claims, prescription and laboratory data in US private settings

Sexually transmitted diseases, 2021-03, Vol.48 (3), p.167-173

2021

Link zum Volltext

Verfügbarkeit prüfen

Expenditures in Young Adults with Hodgkin Lymphoma: NCI-Designated Comprehensive Cancer Centers versus Other Sites

Cancer epidemiology, biomarkers & prevention, 2022-01, Vol.31 (1), p.142-149

2022

Link zum Volltext

Verfügbarkeit prüfen

Some Cautions on the Use of Instrumental Variables Estimators in Outcomes Research: How Bias in Instrumental Variables Estimators Is Affected by Instrument Strength, Instrument Contamination, and Sample Size

Value in health, 2011-12, Vol.14 (8), p.1078-1084

2011

Link zum Volltext

Verfügbarkeit prüfen

Adverse events among chronic myelogenous leukemia patients treated with tyrosine kinase inhibitors: a real-world analysis of health plan enrollees

Leukemia & lymphoma, 2021-04, Vol.62 (5), p.1203-1210

2021

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and short-term outcomes of patients with type 2 diabetes mellitus treated with canagliflozin in a real-world setting

Current medical research and opinion, 2015-01, Vol.31 (1), p.137-143

2015

Link zum Volltext

Verfügbarkeit prüfen

A Retrospective Study to Examine Healthcare Costs Related to Cardiovascular Events in Individuals with Hyperlipidemia

Advances in therapy, 2015-11, Vol.32 (11), p.1104-1116

2015

Link zum Volltext

Verfügbarkeit prüfen

Novel Type 2 Diabetes Medication Access and Effect of Patient Cost Sharing

Journal of managed care & specialty pharmacy, 2018-09, Vol.24 (9), p.847

2018

Link zum Volltext

Verfügbarkeit prüfen

Contemporary trends and barriers to oral anticoagulation therapy in Non-valvular atrial fibrillation during DOAC predominant era

International journal of cardiology. Heart & vasculature, 2023-06, Vol.46, p.101212-101212, Article 101212

2023

Link zum Volltext

Verfügbarkeit prüfen

Real-World Canagliflozin Utilization: Glycemic Control Among Patients With Type 2 Diabetes Mellitus—A Multi-Database Synthesis

Clinical therapeutics, 2016-09, Vol.38 (9), p.2071-2082

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 283

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(259)
Mit Volltextzugriff
(258)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(164)
Life Sciences & Biomedicine
(145)
Humans
(112)
Male
(71)
Female
(60)
Middle Aged
(48)
Biological And Medical Sciences
(44)
Adult
(41)
Aged
(33)
Animals
(30)
Medical Sciences
(28)
Retrospective Studies
(27)
Fundamental And Applied Biological Sciences. Psychology
(19)
Urology & Nephrology
(19)
Infectious Diseases
(15)
Patients
(15)
Social Sciences
(15)
Physical Sciences
(14)
Prostate Cancer
(14)
Oncology
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Pegfilgrastim prophylaxis is associated with a lower risk of hospitalization of cancer patients than filgrastim prophylaxis: a retrospective United States claims analysis of granulocyte colony-stimulating factors (G-CSF)

Patterns of biologic agent utilization among patients with rheumatoid arthritis: a retrospective cohort study

Opioid Prescribing for Opioid-Naive Patients in Emergency Departments and Other Settings: Characteristics of Prescriptions and Association With Long-Term Use

Severe Hypoglycemia Attributable to Intensive Glucose-Lowering Therapy Among US Adults With Diabetes: Population-Based Modeling Study, 2011-2014

Trends in opioid use in commercially insured and Medicare Advantage populations in 2007-16: retrospective cohort study

Health Care Costs and Resource Utilization, Including Patient Burden, Associated With Novel‐Agent‐Based Treatment Versus Other Therapies for Multiple Myeloma: Findings Using Real‐World Claims Data

Methods and Study Design for Cancer Health Economics Research: Summary of Discussions From a Breakout Session

Maternal comorbidity and adverse perinatal outcomes in survivors of adolescent and young adult cancer: A cohort study

Idiopathic pulmonary fibrosis in the United States: time to diagnosis and treatment

Long-term antimüllerian hormone patterns differ by cancer treatment exposures in young breast cancer survivors

Real-world Analysis of Tyrosine Kinase Inhibitor Treatment Patterns Among Patients With Chronic Myeloid Leukemia in the United States

Sexually Transmitted Infection Testing and Prevalence Before and After Preexposure Prophylaxis Initiation Among Men Aged ≥18 Years in US Private Settings

Percutaneous Left Atrial Appendage Occlusion in Comparison to Non-Vitamin K Antagonist Oral Anticoagulant Among Patients With Atrial Fibrillation

Association of Generic Imatinib Availability and Pricing With Trends in Tyrosine Kinase Inhibitor Use in Patients With Chronic Myelogenous Leukemia

A Population-based Study of Immunotherapy-related Toxicities in Lung Cancer

An Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients With Advanced Non-Small-Cell Lung Cancer

Estimating recommended gonorrhea and chlamydia treatment rate using linked medical claims, prescription and laboratory data in US private settings

Expenditures in Young Adults with Hodgkin Lymphoma: NCI-Designated Comprehensive Cancer Centers versus Other Sites

Some Cautions on the Use of Instrumental Variables Estimators in Outcomes Research: How Bias in Instrumental Variables Estimators Is Affected by Instrument Strength, Instrument Contamination, and Sample Size

Adverse events among chronic myelogenous leukemia patients treated with tyrosine kinase inhibitors: a real-world analysis of health plan enrollees

Characteristics and short-term outcomes of patients with type 2 diabetes mellitus treated with canagliflozin in a real-world setting

A Retrospective Study to Examine Healthcare Costs Related to Cardiovascular Events in Individuals with Hyperlipidemia

Novel Type 2 Diabetes Medication Access and Effect of Patient Cost Sharing

Contemporary trends and barriers to oral anticoagulation therapy in Non-valvular atrial fibrillation during DOAC predominant era

Real-World Canagliflozin Utilization: Glycemic Control Among Patients With Type 2 Diabetes Mellitus—A Multi-Database Synthesis

Suchergebnisse filtern